375 related articles for article (PubMed ID: 21142624)
1. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
Zhang R; Rong X; Pan W; Peng T
Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
[TBL] [Abstract][Full Text] [Related]
3. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z
Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575
[TBL] [Abstract][Full Text] [Related]
5. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
[TBL] [Abstract][Full Text] [Related]
6. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
7. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies.
Stelzer-Braid S; Wong B; Robertson P; Lynch GW; Laurie K; Shaw R; Barr I; Selleck PW; Baleriola C; Escott R; Katsoulotos G; Rawlinson WD
J Clin Virol; 2008 Oct; 43(2):241-3. PubMed ID: 18675584
[TBL] [Abstract][Full Text] [Related]
8. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
[TBL] [Abstract][Full Text] [Related]
9. Sparse serological evidence of H5N1 avian influenza virus infections in domestic cats, northeastern China.
Sun L; Zhou P; He S; Luo Y; Jia K; Fu C; Sun Y; He H; Tu L; Ning Z; Yuan Z; Wang H; Li S; Yuan L
Microb Pathog; 2015 May; 82():27-30. PubMed ID: 25752867
[TBL] [Abstract][Full Text] [Related]
10. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
[TBL] [Abstract][Full Text] [Related]
11. [Serological survey on antibodies to influenza A viruses subtype H1, H3, H5 and H9 of population in Shanghai].
Lv XH; Jiang CY; Zhou YB
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):302. PubMed ID: 19642392
[No Abstract] [Full Text] [Related]
12. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
13. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
[TBL] [Abstract][Full Text] [Related]
14. Population exposure to a novel influenza A virus over three waves of infection.
Adamson WE; McGregor EC; Kavanagh K; McMenamin J; McDonagh S; Molyneaux PJ; Templeton KE; Carman WF
J Clin Virol; 2011 Dec; 52(4):300-3. PubMed ID: 21924675
[TBL] [Abstract][Full Text] [Related]
15. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
van der Velden MV; Geisberger A; Dvorak T; Portsmouth D; Fritz R; Crowe BA; Herr W; Distler E; Wagner EM; Zeitlinger M; Sauermann R; Stephan C; Ehrlich HJ; Barrett PN; Aichinger G
Clin Vaccine Immunol; 2014 Jun; 21(6):867-76. PubMed ID: 24739978
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
[TBL] [Abstract][Full Text] [Related]
18. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
19. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.
Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304
[TBL] [Abstract][Full Text] [Related]
20. Comparative analytical sensitivities of six rapid influenza A antigen detection test kits for detection of influenza A subtypes H1N1, H3N2 and H5N1.
Chan KH; Lam SY; Puthavathana P; Nguyen TD; Long HT; Pang CM; Chan KM; Cheung CY; Seto WH; Peiris JS
J Clin Virol; 2007 Feb; 38(2):169-71. PubMed ID: 17194622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]